Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept vs MMF in Pemphigus Vulgaris
NCT05303272Phase 4Unknown
- Sponsor
- Tongji Hospital
- Start
- Feb 2021
- Primary completion
- Sep 2022
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of abatacept in pemphigus vulgaris (PV), sponsored by Tongji Hospital. Status: unknown.
02
Drugs
abatacept
03
Conditions
pemphigus vulgaris (PV)
Beyond the preview
Go deeper on NCT05303272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05303272.